Generic Vytorin
At this time, generic Vytorin is not available. As this eMedTV resource explains, until all applicable patents for the drug have expired, other drug manufacturers are ...
Merck, Schering-Plough split sales on cholesterol drugs ...
Sales for Vytorin, a cholesterol-treating combination produced by Merck and ... cholesterol combo drug, but future uncertain with Zocor's impending patent loss. ...
Vytorin Study Results Cause Stocks To Sink - CBS News
Merck, Schering-Plough Take A Hit; Congress To Investigate Delayed Study Release ... patent expirations, while Merck was about to launch the biggest ...
Pharmacy professor questions Vytorin use | Gainesville.com ...
... Take Vytorin.Then came ... Vytorin (and a sister drug, Zetia) has been a proven money ... The makers of Vytorin hold the patent on their new medication, ...
Full speed ahead for Vytorin II at Merck, Schering ...
... disastrous results of the recent Vytorin study have apparently done nothing to ... More stories about patent Merck Lipitor cholesterol drug AstraZeneca Schering ...
Schering-Plough, Merck In Panic As Another Vytorin Trial ...
Most readers are aware of the ongoing Vytorin scandal and the ... THE VYTORIN PATENT EXPIRES in 2017 -- AND QUESTION AUTHORITY PREDICTS THAT THE ...
Drug patent expiration dates, challenges, sales figures ...
DrugPatentWatch.com - Drug patent expiration, inter partes ex parte reexamination, paragraph IV challenge, sales, therapeutic class, dosage, uspto PDF, generic, FDA
Reading Between the Vytorin - Zocor - Zetia Headlines
The new, combined, branded drug -- new patent and all -- was called Vytorin. ... Patent Info. Privacy Policy. Our Story. Be a Guide ...
For Schering-Plough a new cholesterol drug may be king - Mar ...
Vytorin is a combination of two other cholesterol drugs: Merck's Zocor and ... primarily because earnings took a huge hit after Claritin went off patent in 2003. ...
Anti-Cholesterol Drug Bombs In Tests - cbs2.com
Shares of Merck & Co. and Schering-Plough Corp. fell Monday after study results showed their combination cholesterol drug Vytorin worked no better at reducing ...